Johannes Gutenberg-Universität Mainz
- 6131/39-0
Klimek, Ludger; Huppertz, Tilman; Alali, Ali et al.
A new form of irritant rhinitis to filtering facepiece particle (FFP) masks (FFP2/N95/KN95 respirators) during COVID-19 pandemicWORLD ALLERGY ORGANIZATION JOURNAL. Bd. 13. H. 10. 2020
Corsi, Gabriele; Nava, Stefano; Barco, Stefano
A new tool to measure the long-term global functional status of patients with coronavirus disease 2019: the PCFS (Post-COVID-19 Functional Status) scaleGIORNALE ITALIANO DI CARDIOLOGIA. Bd. 21. H. 10. 2020 S. 757-757
Buhl, Roland; Dreher, Michael; Korn, Stephanie et al.
A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT (R) Study ProtocolINTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Bd. 15. 2020 S. 2601-2608
Haeuser, Friederike; Goekce, Seyfullah; Werner, Gesa et al.
A non-invasive diagnostic assay for rapid detection and characterization of aberrant mRNA-splicing by nonsense mediated decay inhibitionMOLECULAR GENETICS AND METABOLISM. Bd. 130. H. 1. 2020 S. 27-35
Kahaly, George J.; Stan, Marius Nicolae; Frommer, Lara et al.
A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism-A Proof-of-Concept TrialJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 105. H. 3. 2020 S. 696-704
Hermanns, Pia; Classen, Charlotte; Pohlenz, Joachim
A Novel Homozygous Mutation in the Solute Carrier Family 26 Member 7 Gene Causes Thyroid Dyshormonogenesis in a Girl with Congenital HypothyroidismTHYROID. 2020
Zaer, Hamed; Fan, Wei; Orlowski, Dariusz et al.
A Perspective of International Collaboration Through Web-Based Telecommunication-Inspired by COVID-19 CrisisFRONTIERS IN HUMAN NEUROSCIENCE. Bd. 14. 2020
Lopez, Juanita S.; Camidge, Ross; Iafolla, Marco et al.
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumorsCANCER RESEARCH. Bd. 80. H. 16. 2020
Fottner, C.; Apostolidis, L.; Ferrata, M. et al.
A Phase II, Open-Label, Multicenter Trial of Avelumab in Patients with Advanced, Metastatic High Grade Neuroendocrine Carcinomas NEC G3 (WHO 2010) Progressive after First-line Chemotherapy (AVENEC)NEUROENDOCRINOLOGY. Bd. 110. 2020 S. 224-224
Borad, Mitesh J.; Bridgewater, John A.; Morizane, Chigusa et al.
A phase III study of futibatinib (TAS-120) versus gemcitabine-cisplatin (gem-cis) chemotherapy as first-line (1L) treatment for patients (pts) with advanced (adv) cholangiocarcinoma (CCA) harboring fibroblast growth factor receptor 2 (FGFR2) gene rearrangements (FOENIX-CCA3)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020